Article Details
Retrieved on: 2024-02-26 18:56:04
Tags for this article:
Click the tags to see associated articles and topics
Summary
The City of Hope team's innovation strategy for battling acute myeloid leukemia (AML) involves a CD38-BIONIC antibody that targets CD38-positive leukemia stem cells, offering a potential new treatment that spares healthy cells. Relevant tags include biotechnology, stem cell research, and leukemia.
Article found on: www.synbiobeta.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here